Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0000950123-10-110724
Filing Date
2010-12-03
Accepted
2010-12-03 13:02:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 POST EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 c09287posam.htm POS AM 16827
  Complete submission text file 0000950123-10-110724.txt   18303
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-128030 | Film No.: 101230669
SIC: 2835 In Vitro & In Vivo Diagnostic Substances